<DOC>
	<DOCNO>NCT02955186</DOCNO>
	<brief_summary>The purpose study evaluate effect study medication , saracatinib/AZD0530 ( placebo 125 mg/day ) alcohol drink behavior laboratory set participant give initial drink alcohol follow choice drink 12 drink three-hour period . The investigator hypothesize saracatinib reduce crave number drink consume prior exposure initial drink alcohol three hour drink period .</brief_summary>
	<brief_title>Saracatinib Alcohol Drinking</brief_title>
	<detailed_description />
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Saracatinib</mesh_term>
	<criteria>Ages 2150 Able read English 6th grade level high complete study evaluation Regular alcohol drinker Individuals seek alcohol treatment Medical condition would contraindicate use saracatinib Regular use substance</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>